Heat Biologics (NASDAQ:HTBX) is the latest company to jump on the coronavirus bandwagon with its announcement
that subsidiary Zolovax has formally launched a program to develop a
vaccine for treating or preventing infection from SARS-CoV-2, the
coronavirus causing the current outbreak (COVID-19).
It has also filed a provisional patent application covering the use of its gp96 vaccine platform for the potential indication.
Shares up 10% premarket on robust volume.
https://seekingalpha.com/news/3547975-heat-biologics-joins-coronavirus-wave-vaccine-plan-shares-up-10-premarket
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.